A class of molecules called microRNAs may offer cancer patients two ways to combat their disease.

Researchers at Princeton University have found that microRNAs - small bits of genetic…

A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make…

Cancer immunotherapy can successfully use the body’s own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical…

A chemical found in red wine remains effective at fighting cancer even after the body’s metabolism has converted it into other compounds.

This is an…

In 2006 when doctors started testing a melanoma treatment made by Roche Holding AG on patients, they were used to facing slim odds - about one in eight…

Married cancer patients are less likely to die of their disease than those who aren’t wed, a new study suggests.

The study, of more than 730,000 people who…

Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could…

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information…

Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new…

When a child is diagnosed with cancer, one of the first questions the parents ask is “Will my other children get cancer?” A new study from…

The results of a large-scale analysis of the association between DNA viruses and human malignancies suggest that many of the most common cancers are not associated with DNA viruses.…

St. Jude Children’s Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing…

Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace…

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure…

Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4. Each of these antibodies binds to…

Scientists from ETH Zurich have developed a new substance that enables certain tumour types to be rendered visible in high resolution using positron emission tomography. The so-called tracer has successfully been…

In a survey of patients with terminal lung cancer, nearly two-thirds did not understand that radiation treatments intended only to ease their symptoms would not cure their disease.

Among…

A study led by St. Jude Children’s Research Hospital shows epigenetic changes that turn genes on and off are as unique as alterations in…

What started as a dinner-table conversation between a teen and his father has become a bonafide cancer research study for Matthew Lara, a Davis High School…

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for…

Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That’s according to a new study, by Floortje…

Coming at the end of this week is an opportunity to help our neighbors financially and emotionally.

It is the annual Pickens County Relay for Life and has become…

Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of…

When it comes to a cancer diagnosis, timing can be everything - the sooner it’s found, the more treatable it is. But when…

A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc’s cancer therapy for a rare form of eye cancer that spreads to the liver,…